At-home testing startup raised $71 million for its Series C, the company announced Wednesday.
Subscribe to the 蹤獲弝け Daily
The new round, which was co-led by and , will be used to increase its supply, manufacturing and testing capabilities for COVID-19, the company said in a statement. The funding will also be used to expand the company���s supply and business operations across the United States and Europe and strengthen partnerships with insurers and employers, according to the company.
���We have been developing our platform for more than five years and have helped hundreds of thousands of individuals by enabling access to high-quality testing and telehealth services in the home, across many health conditions,��� CEO Peter Foley said in a statement. ���With the onset of COVID-19, we realigned resources with a view to helping with this global pandemic and are currently delivering tens of thousands of tests per day to critical and frontline healthcare workers.���
The company���s COVID-19 tests include an antibody serology test, which produces results within 15 minutes, and a PCR-based test, which requires a swab from the patient that is sent to a lab.
LetsGetChecked also offers other types of testing, including for diabetes, cholesterol, fertility testing and cancer screening.
LetGetChecked is among a growing number of startups that offer at-home testing. Nurx and Everlywell are other prominent players in the space, with both offering STI testing, and Everlywell also offering food sensitivity, thyroid tests and others.
Illustration Credit:
Stay up to date with recent funding rounds, acquisitions, and more with the 蹤獲弝け Daily.


67.1K Followers